Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

BridgeBio Pharma (BBIO) Change in Intangibles (2024 - 2025)

BridgeBio Pharma (BBIO) has disclosed Change in Intangibles for 2 consecutive years, with $2.4 million as the latest value for Q3 2025.

Quarterly Change in Intangibles rose 50.47% to $2.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.5 million through Dec 2025, up 6.52% year-over-year, with the annual reading at $8.5 million for FY2025, 6.52% up from the prior year.
Change in Intangibles hit $2.4 million in Q3 2025 for BridgeBio Pharma, down from $4.5 million in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $4.5 million in Q2 2025 to a low of $797000.0 in Q1 2024.